Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Femasys Inc. stock logo
FEMY
Femasys
$0.88
-2.2%
$1.04
$0.69
$1.80
$22.49M-2.62261,381 shs63,673 shs
Fonar Corporation stock logo
FONR
Fonar
$14.06
-0.1%
$13.26
$12.00
$18.68
$87.22M0.9916,884 shs17,800 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$2.47
+2.1%
$2.52
$0.82
$3.38
$89.85M1.141.74 million shs698,234 shs
Nutriband Inc. stock logo
NTRB
Nutriband
$7.79
+0.5%
$6.22
$3.72
$11.78
$86.89M1.1180,715 shs29,449 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Femasys Inc. stock logo
FEMY
Femasys
0.00%-4.86%-18.52%-45.00%-7.85%
Fonar Corporation stock logo
FONR
Fonar
0.00%-3.03%-0.50%+1.59%-7.92%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.00%-0.40%-5.73%+45.29%+142.16%
Nutriband Inc. stock logo
NTRB
Nutriband
0.00%+2.50%+39.36%+15.75%+50.10%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Femasys Inc. stock logo
FEMY
Femasys
2.9162 of 5 stars
3.53.00.00.02.42.50.6
Fonar Corporation stock logo
FONR
Fonar
1.2797 of 5 stars
0.03.00.00.02.00.81.9
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2.1772 of 5 stars
3.52.00.00.03.30.00.6
Nutriband Inc. stock logo
NTRB
Nutriband
1.9616 of 5 stars
3.52.00.00.01.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Femasys Inc. stock logo
FEMY
Femasys
3.00
Buy$8.67884.85% Upside
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00264.37% Upside
Nutriband Inc. stock logo
NTRB
Nutriband
3.00
Buy$13.0066.88% Upside

Current Analyst Ratings Breakdown

Latest FEMY, MBOT, FONR, and NTRB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
5/13/2025
Femasys Inc. stock logo
FEMY
Femasys
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $6.00
5/9/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
4/10/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
3/28/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Femasys Inc. stock logo
FEMY
Femasys
$1.63M13.79N/AN/A$0.10 per share8.80
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.85$3.08 per share4.57$24.78 per share0.57
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.17 per shareN/A
Nutriband Inc. stock logo
NTRB
Nutriband
$2.14M40.59N/AN/A$0.46 per share16.93
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Femasys Inc. stock logo
FEMY
Femasys
-$18.82M-$0.91N/AN/AN/A-1,242.06%-392.45%-137.15%8/14/2025 (Estimated)
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2511.25N/A8.19%5.31%3.97%N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$11.44M-$0.65N/AN/AN/AN/A-110.27%-94.20%8/13/2025 (Estimated)
Nutriband Inc. stock logo
NTRB
Nutriband
-$10.48M-$0.90N/AN/AN/A-415.93%-68.25%-60.40%9/2/2025 (Estimated)

Latest FEMY, MBOT, FONR, and NTRB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/30/2025Q1 2026
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.13-$0.12+$0.01-$0.12$0.71 million$0.67 million
5/21/2025Q1 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.15-$0.08+$0.07-$0.08N/AN/A
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
5/8/2025Q1 2025
Femasys Inc. stock logo
FEMY
Femasys
-$0.17-$0.23-$0.06-$0.23$1.14 million$0.34 million
4/28/2025Q4 2025
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.12-$0.18-$0.06-$0.51$0.71 million$0.64 million
3/27/2025Q4 2024
Femasys Inc. stock logo
FEMY
Femasys
-$0.25-$0.23+$0.02-$0.23$1.66 million$0.58 million
3/26/2025Q4 2024
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.18-$0.20-$0.02-$0.20N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Femasys Inc. stock logo
FEMY
Femasys
N/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Femasys Inc. stock logo
FEMY
Femasys
0.02
0.93
0.54
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
16.19
16.19
Nutriband Inc. stock logo
NTRB
Nutriband
0.01
3.71
3.48

Institutional Ownership

CompanyInstitutional Ownership
Femasys Inc. stock logo
FEMY
Femasys
65.27%
Fonar Corporation stock logo
FONR
Fonar
50.64%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Nutriband Inc. stock logo
NTRB
Nutriband
19.70%

Insider Ownership

CompanyInsider Ownership
Femasys Inc. stock logo
FEMY
Femasys
11.54%
Fonar Corporation stock logo
FONR
Fonar
1.55%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
Nutriband Inc. stock logo
NTRB
Nutriband
54.09%
CompanyEmployeesShares OutstandingFree FloatOptionable
Femasys Inc. stock logo
FEMY
Femasys
3025.55 million22.60 millionNot Optionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2036.38 million34.65 millionOptionable
Nutriband Inc. stock logo
NTRB
Nutriband
1011.15 million5.12 millionNot Optionable

Recent News About These Companies

Nutriband CEO Publishes Letter to Shareholders
Nutriband granted patent in Macao for its AVERA systems

New MarketBeat Followers Over Time

Media Sentiment Over Time

Femasys stock logo

Femasys NASDAQ:FEMY

$0.88 -0.02 (-2.22%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$0.90 +0.03 (+2.84%)
As of 06/18/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Fonar stock logo

Fonar NASDAQ:FONR

$14.06 -0.02 (-0.14%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$13.91 -0.15 (-1.07%)
As of 06/18/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$2.47 +0.05 (+2.07%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$2.48 +0.01 (+0.61%)
As of 06/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Nutriband stock logo

Nutriband NASDAQ:NTRB

$7.79 +0.04 (+0.52%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$7.60 -0.19 (-2.44%)
As of 06/18/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.